Skip to content

Echovirus IgM Control Serum BC135M

$94.00

Summary

  • Virion/Serion Diagnostic Kit Control for research use (RUO)
  • Echovirus IgM Control Serum
  • Applications: ELISA
  • IgM control serum
  • Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
  • 3 mL

Order now and receive on May 30, 2024

Calculate shipping price

Please fill in the fields below with the shipping destination details in order to calculate the shipping cost.

Weight1 lbs
Dimensions9 × 5 × 2 in
target

Echovirus reactive IgM

species reactivity

Echovirus

applications

ELISA

assay type

Indirect & quantitative

available size

3 mL

kit
Research area
Infectious Disease
Storage
Store at 2-8°C.
Associated products
Echovirus Antigen (BA135VS01)
Echovirus IgA Control Serum (BC135A)
Echovirus IgG Control Serum (BC135G)
Echovirus IgM Control Serum (BC135M)
Echovirus IgG ELISA Kit (ESR135G)
Echovirus IgA ELISA Kit (ESR135A)
Echovirus IgM ELISA Kit (ESR135M)
target relevance
Organism
Echovirus
Structure and strains
Echovirus is a polyphyletic group of viruses associated with enteric disease in humans. The name is derived from "enteric cytopathic human orphan virus". These viruses were originally not associated with disease, but many have since been identified as disease-causing agents. The term "echovirus" was used in the scientific names of numerous species, but all echoviruses are now recognized as strains of various species, most of which are in the family Picornaviridae.
Disease
ECHO virus is an acronym for Enteric Cytopathic Human Orphan virus. The first ECHO viruses were identified in the early 1950's from isolates of infected children's stool samples. The surface of the icosahedral virus capsid consists of the structural proteins VP1, VP2 and VP3, which are responsible for the antigenic properties and the division into the various serotypes.

Transmission of ECHO viruses between hosts occurs primarily by direct contact or droplet infection. In addition, the virus may be transmitted via the placenta. A further important source of infection is contaminated drinking water. The incubation period is generally 3 to 5 days. Some 90 to 95% of all ECHO virus infections are asymptomatic or manifest with unspecific febrile symptoms and are therefore frequently not identified. Clinical diseases resulting from ECHO virus infection manifest as; upper respiratory tract infection (summer flu), pneumonia, pleurodynia, herpangina, hand foot and mouth disease, febrile generalised exanthems, conjunctivitis, gastroenteritis, or Myalgia epidemica. Additionally, ECHO viruses are the most important cause of febrile infection with aseptic meningitis and encephalitis. Infections during the perinatal period of pregnancy are particularly dangerous and may lead to liver failure and myocarditis in the newborn child. Infections with ECHO viruses occur throughout the year but do show a seasonal increase during the summer and autumn months in temperate regions.
Detection and diagnosis
The demonstration of infection by the detection of specific antibodies generally requires the analysis of serum pairs. A positive result for IgM or IgA combined with rising IgG activity serves as clear evidence of an acute or recent infection. Persisting IgM and

Data

Publications

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.

pmidtitleauthorscitation

Protocols

relevant to this product
BC135M protocol

Documents

#
No results found

Reviews

There are no reviews yet.

Be the first to review “Echovirus IgM Control Serum BC135M”